JAZZ Jazz Pharmaceuticals plc
$245.80▲ +2.21%
Healthcare
Other
After hours
$245.80▲ +0.00%
Sep 11, 7:30 PM ET
Volume 422.9K
Avg Volume (10D) 1.21M
Key Metrics & Fundamentals
Market Cap
$15.96B
P/E Ratio
16.8
Div Yield
–%
52W Range
123.88 - 266.38
% vs 50 MA
-1.41%
% vs 200 MA
18.86%
RSI-14
48.2
MACD Histogram
-0.9100
Beta (1Y vs SPY)
0.54
Free Cash Flow
$243.40M
Gross Rev
$1.21B
Gross Profit
$1.09B
EBITDA
$504.30M
COGS
$116.40M
Operating Exp
$766.70M
Operating Income
$325.20M
EBIT
$325.20M
Pretax Income
$211.00M
Net Income
$192.80M
EPS (Diluted)
2.78
Price & Volume History
Loading chart…
Recent News

3 Cash-Producing Stocks We’re Skeptical Of
StockStory · Sep 12, 2026 12:51 AM

2 Reasons to Avoid JAZZ and 1 Stock to Buy Instead
StockStory · Sep 11, 2026 7:39 PM
Jazz Pharmaceuticals Sees Meaningful Long-Term Value From Ziihera's Pursuits Beyond GEA, UBS Says
MT Newswires · Sep 11, 2026 4:00 PM
UBS Adjusts Jazz Pharmaceuticals PT to $337 From $315, Maintains Buy Rating
MT Newswires · Sep 11, 2026 1:21 PM

1 Value Stock with Exciting Potential and 2 We Brush Off
StockStory · Sep 8, 2026 7:43 PM

Quoin in line for priority review voucher if rare paediatric drug approved
Pharmaceutical Technology · Sep 8, 2026 5:28 PM

Jazz (JAZZ) Says Ziihera Beat Trastuzumab on Overall Survival. Can it Replace the First-Line HER2 Backbone?
Insider Monkey · Sep 4, 2026 5:32 PM

Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
PR Newswire · Sep 2, 2026 8:15 PM

Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report?
Zacks · Sep 2, 2026 3:30 PM

Duncan Ferguson Joins Neovii Pharmaceuticals AG to Lead Global Commercial Expansion as Chief Commercial Officer
NewMediaWire · Sep 1, 2026 8:48 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See JAZZ's money flow as a full page
Social Sentiment
Avg +0.05 · 2 posts
NewsDiscussionTradeUp 131% on $ABCL and the AI drug discovery train is leaving the station. 🚂💊📈
r/wallstreetbets · Aug 11, 2026
Partnership agreement drives positive sentiment related to ABCL and the company.
positive
+0.80
NewsDiscussionMemeIt's ok for now. “It’s going to be ugly,” Scott Galloway issues stark warning - highly inflated valuations of Mag 10 and other “red flags”.
r/wallstreetbets · Nov 11, 2025
Associated with speculative, 'vaporware' AI ventures.
negative
-0.70
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.